BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Verastem, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 5:03 pm Sale | 2025-08-11 | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 2,500,000 3.900% | -3,220,831 (-56.30%) | Filing |
| 2025-08-13 5:00 pm Purchase | 2025-06-30 | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 5,720,831 9.990% | 1,014,280 (+21.55%) | Filing |
| 2025-02-14 4:26 pm Purchase | 2024-12-31 | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 4,706,551 9.990% | 427,030 (+9.98%) | Filing |
| 2024-11-14 4:38 pm Purchase | 2024-09-30 | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 4,279,521 9.990% | 1,662,119 (+63.50%) | Filing |
| 2024-02-14 09:20 am Purchase | 2023-12-31 | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 2,617,402 9.990% | 942,863 (+56.31%) | Filing |